Pancreatic Cancer Research

ResearcherNankai UniversityNo recent work listed

Cheng Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2126-282X; OpenAlex author ID A5100705023. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2021: 1 paper · 2022: 2 papers · 2023: 1 paper

Papers 4

  1. A phenylpentane derivative from Sanghuangporus vaninii inhibits EMT mediated tumor progression of pancreatic cancer by targeting EGFR Last author DOI 10.22541/au.170055386.61441566/v1↗
  2. TMEM43 promotes pancreatic cancer progression by stabilizing PRPF3 and regulating RAP2B/ERK axis. Co-author DOI 10.1186/s11658-022-00321-z↗
  3. Comprehensive Analysis of 5-Methylcytosine (m5C) Regulators and the Immune Microenvironment in Pancreatic Adenocarcinoma to Aid Immunotherapy. Co-author DOI 10.3389/fonc.2022.851766↗
  4. Comprehensive Analysis of m6A RNA Methylation Regulators and the Immune Microenvironment to Aid Immunotherapy in Pancreatic Cancer. Co-author DOI 10.3389/fimmu.2021.769425↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yongdong Guo · 3 shared papers, 2021–2022 · strength 0.37
  2. Junqiang Li · 3 shared papers, 2021–2022 · strength 0.37
  3. Ronglin Wang · 3 shared papers, 2021–2022 · strength 0.37
  4. Lei Hua · 3 shared papers, 2021–2022 · strength 0.37
  5. Haichuan Su · 3 shared papers, 2021–2022 · strength 0.37
  6. Yang Song · 2 shared papers, 2021–2022 · strength 0.24
  7. Ting Zhao · 2 shared papers, 2021–2022 · strength 0.24
  8. Ting Xiao · 1 shared paper, 2023 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.